Kurt Phinney - 23 May 2023 Form 3 Insider Report for AXIM BIOTECHNOLOGIES, INC. (AXIM)

Role
Chief Operating Officer
Signature
/s/ Kurt Phinney
Issuer symbol
AXIM
Transactions as of
23 May 2023
Net transactions value
$0
Form type
3
Filing time
30 May 2023, 14:19:03 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AXIM Option 23 May 2023 Common Stock 2,000,000 $0.0200 Held by Accalle, LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Accalle, LLC is a limited liability company wholly owned by Reporting Person.